Press Release: Narayana Health Issues Statement Regarding Spire Healthcare Group plc ("Spire")

Dow Jones
2024-11-29
Narayana Health Issues Statement Regarding Spire Healthcare Group plc ("Spire") 
 
 
LONDON--(BUSINESS WIRE)--November 29, 2024-- 
 
   In response to recent media speculation, Narayana Health confirms that 
it does not intend to make an offer for Spire. This is a statement to 
which Rule 2.8 of the Code applies. Accordingly, Narayana Health (and 
any person acting in concert with it) is, except in the circumstances 
set out below or otherwise with the consent of the Panel on Takeovers 
and Mergers (the "Panel"), bound by the restrictions under Rule 2.8 of 
the Code. 
 
 
   Under Note 2 on Rule 2.8 of the Code, Narayana Health (and any person 
acting in concert with it) reserves the right to set aside the 
restrictions in Rule 2.8 in the following circumstances: 
 
   1. 
 with the agreement of the board of directors of Spire; 
 
 
   2. 

following the announcement of a firm intention to make an offer for

      Spire by or on behalf of a third party; 
 
 
   3. 

following the announcement by Spire of a Rule 9 waiver proposal (as

      described in Note 1 of the Notes on Dispensations from Rule 9 of the 
      Code) or a reverse takeover (as defined in the Code); or 
 
 
   4. 

where the Panel has determined that there has been a material change of

      circumstances. 
 
 
 
   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN 
WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD 
CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH 
JURISDICTION. 
 
 
   THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON 
TAKEOVERS AND MERGERS (THE "CODE"). 
 
 
 

View source version on businesswire.com: https://www.businesswire.com/news/home/20241129854667/en/

 
 
    CONTACT:    18003090309 
 
 
   Feedback.konnect@narayanahealth.org 
 
 
 
 
 
 

(END) Dow Jones Newswires

November 29, 2024 10:02 ET (15:02 GMT)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10